Advisor Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $9K | Sell |
367
-688
| -65% | -$16.9K | ﹤0.01% | 4407 |
|
|
2019
Q3 | $28K | Sell |
1,055
-606
| -36% | -$16.1K | ﹤0.01% | 3749 |
|
|
2019
Q2 | $54K | Sell |
1,661
-1,442
| -46% | -$46.9K | ﹤0.01% | 3303 |
|
|
2019
Q1 | $110K | Buy |
3,103
+1,021
| +49% | +$36.2K | ﹤0.01% | 2776 |
|
|
2018
Q4 | $69K | Buy |
2,082
+306
| +17% | +$10.1K | ﹤0.01% | 2958 |
|
|
2018
Q3 | $90K | Sell |
1,776
-12,218
| -87% | -$619K | ﹤0.01% | 2832 |
|
|
2018
Q2 | $837K | Buy |
13,994
+11,530
| +468% | +$690K | 0.01% | 971 |
|
|
2018
Q1 | $112K | Sell |
2,464
-837
| -25% | -$38K | ﹤0.01% | 2474 |
|
|
2017
Q4 | $132K | Buy |
3,301
+230
| +7% | +$9.2K | ﹤0.01% | 2347 |
|
|
2017
Q3 | $123K | Sell |
3,071
-324
| -10% | -$13K | ﹤0.01% | 2242 |
|
|
2017
Q2 | $146K | Buy |
3,395
+410
| +14% | +$17.6K | ﹤0.01% | 2013 |
|
|
2017
Q1 | $95K | Sell |
2,985
-410
| -12% | -$13K | ﹤0.01% | 2198 |
|
|
2016
Q4 | $85K | Sell |
3,395
-391
| -10% | -$9.79K | ﹤0.01% | 2191 |
|
|
2016
Q3 | $94K | Sell |
3,786
-3,444
| -48% | -$85.5K | ﹤0.01% | 2050 |
|
|
2016
Q2 | $147K | Buy |
+7,230
| New | +$147K | ﹤0.01% | 1671 |
|